News
Investing.com -- Global macro hedge funds and long-only funds have stepped in to support equities just as retail demand has ...
Investing.com -- Danish drugmaker Novo Nordisk (NYSE: NVO) announced Tuesday that Canada’s health regulator has approved its diabetes drug Ozempic for additional uses related to kidney disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback